Skip to main content

Table 2 Common adverse events

From: The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial

Most frequently observed AE resulting from study drug Most frequently observed laboratory abnormalities
Mouth ulcers Neutropenia
Rash Thrombocytopenia
Infections Hypercholesterolemia
Diarrhoea Hypertriglyceridemia
Fatigue Hypophosphatemia
Headache  
Anorexia  
Nausea  
Vomiting  
Non-infectious pneumonitis  
  1. AE adverse events